annual FCF:
$13.80B+$2.09B(+17.87%)Summary
- As of today (August 18, 2025), NVS annual free cash flow is $13.80 billion, with the most recent change of +$2.09 billion (+17.87%) on December 31, 2024.
- During the last 3 years, NVS annual FCF has risen by +$1.76 billion (+14.60%).
- NVS annual FCF is now at all-time high.
Performance
NVS Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$6.19B+$4.04B(+187.79%)Summary
- As of today (August 18, 2025), NVS quarterly free cash flow is $6.19 billion, with the most recent change of +$4.04 billion (+187.79%) on June 30, 2025.
- Over the past year, NVS quarterly FCF has increased by +$2.04 billion (+49.28%).
- NVS quarterly FCF is now -35.20% below its all-time high of $9.55 billion, reached on September 30, 2007.
Performance
NVS quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$16.89B+$2.04B(+13.76%)Summary
- As of today (August 18, 2025), NVS TTM free cash flow is $16.89 billion, with the most recent change of +$2.04 billion (+13.76%) on June 30, 2025.
- Over the past year, NVS TTM FCF has increased by +$5.18 billion (+44.18%).
- NVS TTM FCF is now at all-time high.
Performance
NVS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
NVS Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +17.9% | +49.3% | +44.2% |
3 y3 years | +14.6% | +95.2% | +50.3% |
5 y5 years | +22.0% | +76.8% | +36.5% |
NVS Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +17.9% | at high | +458.2% | at high | +64.9% |
5 y | 5-year | at high | +25.4% | at high | +683.6% | at high | +64.9% |
alltime | all time | at high | +1592.4% | -35.2% | +784.9% | at high | +1690.9% |
NVS Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $6.19B(+187.8%) | $16.89B(+13.8%) |
Mar 2025 | - | $2.15B(-29.8%) | $14.85B(+7.5%) |
Dec 2024 | $13.80B(+17.9%) | $3.06B(-44.2%) | $13.80B(+10.4%) |
Sep 2024 | - | $5.49B(+32.3%) | $12.51B(+6.8%) |
Jun 2024 | - | $4.15B(+273.9%) | $11.71B(+14.3%) |
Mar 2024 | - | $1.11B(-37.1%) | $10.25B(-12.5%) |
Dec 2023 | $11.71B(-2.4%) | $1.76B(-62.4%) | $11.71B(-13.6%) |
Sep 2023 | - | $4.70B(+75.4%) | $13.56B(+2.1%) |
Jun 2023 | - | $2.68B(+4.0%) | $13.29B(-3.6%) |
Mar 2023 | - | $2.57B(-28.8%) | $13.78B(+14.9%) |
Dec 2022 | $12.00B(-0.4%) | $3.61B(-18.3%) | $12.00B(+6.3%) |
Sep 2022 | - | $4.42B(+39.4%) | $11.29B(+0.4%) |
Jun 2022 | - | $3.17B(+301.5%) | $11.24B(-2.9%) |
Mar 2022 | - | $790.00M(-72.8%) | $11.57B(-3.9%) |
Dec 2021 | $12.04B(+9.4%) | $2.90B(-33.6%) | $12.04B(-0.6%) |
Sep 2021 | - | $4.37B(+24.7%) | $12.11B(+18.0%) |
Jun 2021 | - | $3.50B(+178.2%) | $10.26B(+0.0%) |
Mar 2021 | - | $1.26B(-57.6%) | $10.26B(-6.8%) |
Dec 2020 | $11.00B(-2.7%) | $2.98B(+17.9%) | $11.00B(+0.9%) |
Sep 2020 | - | $2.52B(-28.0%) | $10.91B(-11.9%) |
Jun 2020 | - | $3.50B(+74.8%) | $12.37B(+7.3%) |
Mar 2020 | - | $2.00B(-30.4%) | $11.53B(+2.0%) |
Dec 2019 | $11.31B(-2.4%) | $2.88B(-27.9%) | $11.31B(-2.0%) |
Sep 2019 | - | $3.99B(+50.2%) | $11.53B(+7.4%) |
Jun 2019 | - | $2.66B(+49.0%) | $10.74B(-6.9%) |
Mar 2019 | - | $1.78B(-42.5%) | $11.53B(-0.5%) |
Dec 2018 | $11.59B(+17.0%) | $3.10B(-2.9%) | $11.59B(+5.8%) |
Sep 2018 | - | $3.20B(-7.4%) | $10.95B(+0.5%) |
Jun 2018 | - | $3.45B(+87.9%) | $10.89B(+4.4%) |
Mar 2018 | - | $1.84B(-25.6%) | $10.43B(+5.3%) |
Dec 2017 | $9.90B(+15.2%) | $2.47B(-21.4%) | $9.90B(-5.8%) |
Sep 2017 | - | $3.14B(+5.0%) | $10.51B(+15.8%) |
Jun 2017 | - | $2.99B(+127.7%) | $9.08B(+3.7%) |
Mar 2017 | - | $1.31B(-57.3%) | $8.75B(+1.8%) |
Dec 2016 | $8.60B(+2.4%) | $3.08B(+80.8%) | $8.60B(+10.4%) |
Sep 2016 | - | $1.70B(-36.1%) | $7.79B(-9.8%) |
Jun 2016 | - | $2.66B(+130.2%) | $8.63B(+3.8%) |
Mar 2016 | - | $1.16B(-48.9%) | $8.31B(-0.9%) |
Dec 2015 | $8.39B(-20.0%) | $2.27B(-11.0%) | $8.39B(-13.7%) |
Sep 2015 | - | $2.55B(+8.7%) | $9.72B(-10.9%) |
Jun 2015 | - | $2.34B(+89.8%) | $10.91B(-1.1%) |
Mar 2015 | - | $1.24B(-65.6%) | $11.03B(+5.1%) |
Dec 2014 | $10.49B(+7.1%) | $3.60B(-3.7%) | $10.49B(+6.8%) |
Sep 2014 | - | $3.73B(+51.6%) | $9.82B(-2.1%) |
Jun 2014 | - | $2.46B(+252.2%) | $10.04B(+9.6%) |
Mar 2014 | - | $699.56M(-76.1%) | $9.16B(-6.5%) |
Dec 2013 | $9.80B | $2.93B(-25.8%) | $9.80B(-7.8%) |
Sep 2013 | - | $3.95B(+149.1%) | $10.62B(+5.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | $1.58B(+18.4%) | $10.04B(-4.1%) |
Mar 2013 | - | $1.34B(-64.4%) | $10.47B(-5.9%) |
Dec 2012 | $11.13B(-5.7%) | $3.75B(+11.6%) | $11.13B(-1.2%) |
Sep 2012 | - | $3.37B(+67.2%) | $11.26B(-1.6%) |
Jun 2012 | - | $2.01B(+0.9%) | $11.43B(-7.1%) |
Mar 2012 | - | $1.99B(-48.7%) | $12.31B(+4.3%) |
Dec 2011 | $11.80B(+0.5%) | $3.88B(+9.7%) | $11.80B(+0.3%) |
Sep 2011 | - | $3.54B(+22.8%) | $11.76B(+6.3%) |
Jun 2011 | - | $2.88B(+94.0%) | $11.06B(+6.7%) |
Mar 2011 | - | $1.49B(-61.4%) | $10.37B(-11.7%) |
Dec 2010 | $11.74B(+24.6%) | $3.85B(+35.4%) | $11.74B(+3.2%) |
Sep 2010 | - | $2.84B(+29.6%) | $11.37B(+2.2%) |
Jun 2010 | - | $2.19B(-23.3%) | $11.13B(+0.6%) |
Mar 2010 | - | $2.86B(-17.8%) | $11.06B(+13.0%) |
Dec 2009 | $9.42B(+26.4%) | $3.48B(+34.1%) | $9.79B(+9.9%) |
Sep 2009 | - | $2.59B(+21.7%) | $8.91B(+0.8%) |
Jun 2009 | - | $2.13B(+34.5%) | $8.84B(+10.5%) |
Mar 2009 | - | $1.59B(-39.0%) | $8.00B(+4.4%) |
Dec 2008 | $7.45B(+22.6%) | $2.60B(+3.0%) | $7.66B(+51.3%) |
Sep 2008 | - | $2.52B(+95.4%) | $5.06B(-58.1%) |
Jun 2008 | - | $1.29B(+3.4%) | $12.09B(+0.8%) |
Mar 2008 | - | $1.25B(-86.9%) | $11.99B(-3.5%) |
Dec 2007 | $6.08B(+0.0%) | - | - |
Sep 2007 | - | $9.55B(+701.7%) | $12.43B(+186.0%) |
Jun 2007 | - | $1.19B(-29.3%) | $4.35B(-1.6%) |
Mar 2007 | - | $1.69B(+14.8%) | $4.42B(-33.5%) |
Dec 2006 | $6.07B(-6.0%) | - | - |
Sep 2006 | - | $1.47B(+16.5%) | $6.64B(-10.2%) |
Jun 2006 | - | $1.26B(-38.5%) | $7.39B(-6.3%) |
Mar 2006 | - | $2.05B(+10.5%) | $7.89B(+13.9%) |
Dec 2005 | $6.46B(+26.3%) | $1.86B(-16.5%) | $6.92B(+8.8%) |
Sep 2005 | - | $2.22B(+26.3%) | $6.37B(+7.9%) |
Jun 2005 | - | $1.76B(+62.2%) | $5.90B(+8.5%) |
Mar 2005 | - | $1.09B(-16.4%) | $5.44B(+2.7%) |
Dec 2004 | $5.12B(+0.9%) | $1.30B(-26.0%) | $5.30B(+32.5%) |
Sep 2004 | - | $1.75B(+35.0%) | $4.00B(+78.2%) |
Jun 2004 | - | $1.30B(+37.8%) | $2.24B(+137.8%) |
Mar 2004 | - | $943.12M(-60.1%) | $943.12M(-60.1%) |
Dec 2003 | $5.07B(+24.0%) | - | - |
Dec 2002 | $4.09B(-542.3%) | $2.36B | $2.36B |
Dec 2001 | -$924.52M(-150.2%) | - | - |
Dec 2000 | $1.84B(-43.4%) | - | - |
Dec 1999 | $3.25B(+19.2%) | - | - |
Dec 1998 | $2.73B(+132.6%) | - | - |
Dec 1997 | $1.17B(-49.1%) | - | - |
Dec 1996 | $2.30B(-17.3%) | - | - |
Dec 1995 | $2.79B(+90.1%) | - | - |
Dec 1994 | $1.47B(+7.7%) | - | - |
Dec 1993 | $1.36B | - | - |
FAQ
- What is Novartis AG annual free cash flow?
- What is the all time high annual FCF for Novartis AG?
- What is Novartis AG annual FCF year-on-year change?
- What is Novartis AG quarterly free cash flow?
- What is the all time high quarterly FCF for Novartis AG?
- What is Novartis AG quarterly FCF year-on-year change?
- What is Novartis AG TTM free cash flow?
- What is the all time high TTM FCF for Novartis AG?
- What is Novartis AG TTM FCF year-on-year change?
What is Novartis AG annual free cash flow?
The current annual FCF of NVS is $13.80B
What is the all time high annual FCF for Novartis AG?
Novartis AG all-time high annual free cash flow is $13.80B
What is Novartis AG annual FCF year-on-year change?
Over the past year, NVS annual free cash flow has changed by +$2.09B (+17.87%)
What is Novartis AG quarterly free cash flow?
The current quarterly FCF of NVS is $6.19B
What is the all time high quarterly FCF for Novartis AG?
Novartis AG all-time high quarterly free cash flow is $9.55B
What is Novartis AG quarterly FCF year-on-year change?
Over the past year, NVS quarterly free cash flow has changed by +$2.04B (+49.28%)
What is Novartis AG TTM free cash flow?
The current TTM FCF of NVS is $16.89B
What is the all time high TTM FCF for Novartis AG?
Novartis AG all-time high TTM free cash flow is $16.89B
What is Novartis AG TTM FCF year-on-year change?
Over the past year, NVS TTM free cash flow has changed by +$5.18B (+44.18%)